What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport 

Werner Poewe, Günther Deuschl, A Nebe, +8

Journal of Neurology Neurosurgery & Psychiatry

Changes in brain activation associated with reward processing in smokers and nonsmokers

S. Magyar, G. Künig, J. Missimer, +2

Experimental Brain Research

Tobacco ControlNeurobiological MechanismCognitive ScienceReward ProcessingAddiction +7

Correlation between disease severity and brain electric LORETA tomography in Alzheimer’s disease

Lorena R. R. Gianotti, G. Künig, Dietrich Lehmann, +4

Clinical Neurophysiology

Neurodegenerative DiseasesAlzheimer's DiseaseDisease SeverityMedicineVascular Dementia +7

Changes in reward‐induced brain activation in opiate addicts

Chantal Martin‐Soelch, A.‐F. Chevalley, G. Künig, +5

European Journal of Neuroscience

Bradykinesia in early Huntington’s disease

Rosario Sánchez‐Pernaute, G. Künig, Aurora Alba, +3

Neurology

Reduced reward processing in the brains of Parkinsonian patients

G. Künig, Klaus L. Leenders, Chantal Martin‐Soelch, +3

Neuroreport

Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.

G. Künig, Klaus L. Leenders, Rosario Sánchez‐Pernaute, +4

PubMed

Positron Emission TomographyMedicinePsychotropic MedicationInverse RelationshipNeuropharmacology +8

Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity

Jürgen Deckert, Femke Abel, G. Künig, +5

Neuroscience Letters

Alzheimer's DiseaseMedicineDementiaVascular DementiaNeuropharmacology +7

Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease

Lorena R. R. Gianotti, G. Künig, Pascal L. Faber, +4

Psychopharmacology

Neuroimaging BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseBrain FunctionNeurophysiology +11

Costs of Treating Dystonias and Hemifacial Spasm with Botulinum Toxin A

Richard C. Dodel, A. Kirchner, Rudolf Koehne-Volland, +7

PharmacoEconomics

MedicineHemifacial SpasmBotulinum Toxin A